PBX2 and hepatocellular carcinoma: Moreover, TCGA data analysis reveals significant upregulation of both PBX2 and PRMT1 in HCC and kidney renal papillary cell carcinoma, with a strong positive correlation (Figure S13E,F, Supporting Information).